Abo, Melaville O.
HRN: 00-56-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2024
CO-AMOXICLAV 625MG (TAB)
08/29/2024
09/05/2024
PO
500mg Tab
BID
S/P NSVD With RMLE And Repair, PROM X 13 Hrs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes